Study on Combining Smoking Cessation Methods and Low-Dose CT Screening to Detect Lung Cancer in Smokers Aged 50 to 74
Led by Oulu University Hospital · Updated on 2026-02-06
1200
Participants Needed
5
Research Sites
504 weeks
Total Duration
AI-Summary
What This Trial Is About
This research aims to evaluate the effectiveness of different methods to help people stop smoking combined with low-dose CT LDCT screening for lung cancer. It focuses on individuals aged 50 to 74 who have a significant smoking history and are current smokers. The study compares smoking cessation methods, the impact of LDCT screening on lung cancer detection, the stage at which lung cancer is found, and survival specific to lung cancer.
Participants are randomly assigned to one of three groups smoking cessation using a smartphone application plus LDCT screening, smoking cessation using written materials plus LDCT screening, or smoking cessation with the smartphone application alone without LDCT screening. The interventions involve digital support for quitting smoking and lung cancer screening using low-dose CT scans. The study tracks outcomes over time, including smoking cessation rates and lung cancer findings.
During the study, researchers will monitor smoking cessation success at three, 12, and 24 months, verify smoking status with carbon monoxide measurements, and assess lung cancer incidence and screening results at various time points including up to ten years. Participants will be asked to use the assigned smoking cessation method and, if applicable, undergo LDCT scans. The study lasts several years to capture both short- and long-term outcomes related to smoking behavior and lung cancer detection.
CONDITIONS
Brief Title
Integrating Smoking Cessation With Low-dose CT-screening for Lung Cancer
Research Team
J
Jussi P Koivunen, MD, PhD
S
Sanna Iivanainen, MD, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Current smoker who has smoked at least 15 cigarettes per day for 25 years or 10 cigarettes per day for 30 years
Access to a smartphone (iPhone or Android)
You will not qualify if you...
Current or past melanoma, lung, renal, or breast cancer
Chest CT examination less than one year before inclusion
Known psychiatric or substance abuse disorders interfering with trial cooperation
No access to a smartphone (iPhone or Android)
Unwilling or unable to comply with treatment and trial instructions
Any condition considered by investigators to impede safe trial participation
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Treatment
Duration - Up to 24 months
Participants receive smoking cessation support through a smartphone application or written materials, with or without low-dose CT lung cancer screening depending on their assigned study arm.
Baseline visit and periodic follow-up visits for up to 24 months
Follow-up
Duration - Up to 10 years
Participants are monitored for smoking cessation outcomes and lung cancer incidence after treatment ends.
Follow-up visits at 24 months, 36 months, and up to 10 years
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Similar Trials
HealthyCells A Culturally Tailored Smartphone Program to Help African American Adults Quit Smoking and Reduce Sitting Time
Freedom to Breathe Pilot Study Using Indoor Air Quality Monitoring to Promote Smoke-Free Homes for Cancer Patients
Randomized Double-Blind Study of Nicotine Orodispersible Tablet Versus Placebo for Craving Relief in Adult Smokers
Evaluating Vagal Nerve Stimulation Combined with Nicotine Replacement Therapy for Smoking Cessation
Trial of a Culturally Tailored Lung Health Program to Help Chinese and Korean American Smokers Quit and Improve Lung Screening
Advancing Smoking Cessation and Physical Activity Among Latino Adults Using Actvatexto and Decdetexto Mobile Programs
Pilot Study to Adapt and Test a Cognitive-Behavioral Smoking Cessation Program for Transgender and Gender Diverse Adults
Randomized Trial of a Culturally Tailored Digital Smoking Cessation Program for American Indian Adults
Screening Study for Early Detection of Bladder Cancer in High-Risk Adults Age 50 and Older
Comparing Two Brain Stimulation Devices for Smoking Cessation in Schizophrenia Spectrum Disorder Patients
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Smartphone application versus written material for smoking reduction and cessation in individuals undergoing low-dose computed tomography (LDCT) screening for lung cancer: a phase II open-label randomised controlled trial.
Sanna Iivanainen, Antti Kurtti, Viktor Wichmann...